Development of new glucosylated derivatives of gadolinium diethylenetriaminepentaacetic for magnetic resonance angiography

Invest Radiol. 2003 Jun;38(6):320-33.

Abstract

Rationale and objectives: A possible approach for the extension of the vascular residence time of contrast agents relies on the renal reabsorption mechanisms of some molecules such as glucose. In this study, various small-molecular-weight glucosyl derivatives of gadolinium diethylenetriaminepentaacetic (Gd-DTPA) were synthesized and their vascular half-life was studied.

Methods: Several Gd-DTPA-bisamides carrying glucosyl groups bound by different linkers were prepared. The pharmacokinetics and biodistribution of these compounds were determined on Wistar rats.

Results: The sugar moieties linked to Gd-DTPA efficiently reduce the renal excretion of some derivatives. The interaction with renal carrier has not been clearly demonstrated, nor was any interaction observed with blood components.

Conclusions: Two of the new glucosylated derivatives of Gd-DTPA (Cd-DTPA-BC2-beta-cellobionA 2 and Gd-DTPA-BC4-beta-glucosylA 7) can be proposed as blood-pool MR contrast agents, considering their vascular remanence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Contrast Media* / chemistry
  • Contrast Media* / pharmacokinetics
  • Gadolinium DTPA / analogs & derivatives*
  • Humans
  • Magnetic Resonance Angiography*
  • Male
  • Rats
  • Tissue Distribution

Substances

  • Contrast Media
  • Gadolinium DTPA